SproutNews logo

Today’s Research Reports on Stocks to Watch: OraSure Technologies and Sunshine Heart

NEW YORK, NY / ACCESSWIRE / March 22, 2017 / Biotechs stocks have been said to be under pressure as President Trump continues his verbal assault on the high cost of drugs. Not so for the suppliers of medical equipment and devices. Two stocks that showed recent resiliency are OraSure Technologies and Sunshine Heart. One has broken through the obstacle to achieve a company milestone, while the other found financial stability through seeking out new sources of cash.

RDI Initiates Coverage:

OraSure Technologies,
Inc.

https://ub.rdinvesting.com/news/?ticker=OSUR

Sunshine Heart Inc.

https://ub.rdinvesting.com/news/?ticker=SSH

OraSure Technologies stock was up to close on $11.80 a day after Tuesday’s trading day up 91 cents. The company, a developer and manufacturer of oral fluid diagnostic products and specimen collection devices, also markets and sells its products. The news on the day is that the company has been included in the S&P SmallCap 600 from March 23rd, becoming a factor in the Health Care Supplies Sub-Industry index and this may attract more investors. The company announced it has signed a contract worth $18 million on November 29th of last year with an unnamed foreign government for nationwide testing of hepatitis C (HCV) and to supply health care supplies for the same. While the stock price stood at $8.43 that day, by February 9th of this year it rose to $10.49 a share as the news of payment of settlement amount of $12.5 million to its subsidiary with the fourth quarter result of 10 percent higher revenue year over year and earnings of $0.13 a share started coming in and from there it has not looked back. Today’s news has created a definite level of comfort for investors.


Access RDI’s OraSure Technologies Research Report at: https://ub.rdinvesting.com/news/?ticker=OSUR

Sunshine Heart stock took a significant loss on Tuesday, losing almost 28 percent of its value, dropping 78 cents on the day with large volume. The stock closed at a price of $2.05 reaching a 52 week low of $2.02. However, in afterhours trading the stock leaped back up, regaining its day losses. The company made an SEC filing for an offering of Class A units of up to $5 million. Prior to the day’s close, some technical investors were saying that the bottom of Sunshine Heart had not been reached yet. The general technical analysis of the stock has had it down trending for more than a week.

Access RDI’s Sunshine Heart Research Report at: https://ub.rdinvesting.com/news/?ticker=SSH

Our Actionable Research on OraSure Technologies, Inc. (NASDAQ: OSUR) and Sunshine Heart Inc. (NASDAQ: SSH) can be downloaded free of charge at Research Driven Investing.

Research Driven
Investing

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of RDInvesting.com and reviewed by Hemal K. Gandhi, a CFA® charter holder. RDInvesting.com is neither a registered broker dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Address:

Research Driven Investing, Unit #901 511 Avenue of the Americas, New York, NY, 10011

Email:

contact@rdinvesting.com

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: RDInvesting.com

ReleaseID: 457918

Go Top